admin

PEP prevents HIV within 72 hours of unexpected exposure, but few people talk about it.

By Michael Chancley Jr., MSW During my time as a PrEP navigator, I received calls almost every week from people who were frantic about possibly having been exposed to HIV. The scenario played out in many different ways, but almost always included one common feature: none of the callers knew about prophylaxis […]

PEP prevents HIV within 72 hours of unexpected exposure, but few talk about it. Read More »

Why is May 17th the International Day Against Homophobia, Transphobia and Biphobia?

Thousands of initiatives in more than 130 countries, including 37 where same-sex relations are illegal. Since 2005, May 17 has been celebrated as the International Day Against Homophobia, Transphobia and Biphobia, commemorating the removal of homosexuality from the list of mental illnesses by the World Health Organization.

Why is May 17th the International Day Against Homophobia, Transphobia, and Biphobia? Read More »

A potential biomarker indicates in which people HIV therapy could be discontinued

People who contract HIV must follow antiretroviral drug treatment for life to keep the infection under control and prevent transmission to others. However, in some patients, the virus does not reappear when treatment is stopped. These minority cases are known among researchers in the field as post-treatment controllers.

A potential biomarker indicates in which people HIV therapy could be discontinued. Read More »

Now that the public health emergency is coming to an end, how do we feel about it?

By Paul Sax As you no doubt heard, on Friday, May 5, 2023, the WHO declared the end of the global health emergency for COVID-19. Here in the U.S., the federal public health emergency will expire on May 11. That's a Thursday, in just a few days. These events reflect two realities that, although seemingly

Now that the public health emergency is coming to an end, how do we feel about it? Read More »

A novel dual gene-editing method increases the chances of eliminating HIV infection

A gene-editing therapy targeting two entities—HIV-1 and CCR5, the coreceptor that helps the virus enter cells—can effectively eliminate HIV infection. A new study from Temple University's Lewis Katz School of Medicine and the University of California Medical Center shows that this therapy can be effective in treating HIV infection.

A novel dual gene-editing method increases the chances of eliminating HIV infection. Read More »